Seeger Weiss Founder Chris Seeger Awarded Law360 MVP for Product Liability

Seeger Weiss is pleased to announce that founding partner Chris Seeger was honored with a Law360 2023 MVP award for his product liability practice. This prestigious accolade serves as a testament to Chris’ unyielding commitment to holding corporations accountable and pursuing justice for consumers harmed by defective products. Over the course of the past year, […]

October 2, 2023

Chris Seeger Awarded Law360 MVP for Product Liability

Seeger Weiss is pleased to announce that founding partner Chris Seeger was honored with a Law360 2023 MVP award for his product liability practice. This prestigious accolade serves as a testament to Chris’ unyielding commitment to holding corporations accountable and pursuing justice for consumers harmed by defective products.

Over the course of the past year, Chris has secured landmark settlements in some of the most significant product liability cases across the country. Last month, Chris announced a more than $6 billion in the 3M Combat Arms Earplug Litigation, resolving the largest mass tort in US history and ensuring hundreds of thousands of servicemembers and veterans receive compensation for their hearing injuries. And in the National Prescription Opiate Litigation Chris helped negotiate settlements totaling over $13 billion with the big three pharmacies – CVS, Walgreens, and Walmart – which followed the $26 billion global settlement plaintiffs reached with drug distributors McKesson, Cardinal Health and AmerisourceBergen and manufacturer Johnson & Johnson.

Chris currently serves as lead plaintiffs’ counsel in the Philips Recalled CPAP, Bi-PAP, and Mechanical Ventilator Litigation, where he helped achieve an uncapped economic loss settlement worth a minimum of $479 million and continues to represent plaintiffs in personal injury and medical monitoring actions. He also holds the position of lead counsel in the Social Media Adolescent Addiction/Personal Injury Litigation and the Proton-Pump Inhibitor Litigation.

Law360 selects attorneys who “distinguished themselves from their peers by securing hard-earned successes in high-stakes litigation, complex global matters and record-breaking deals.”

Chris’s inclusion in this year’s list from a pool of more than 900 submissions underscores his pivotal role in shaping the landscape of product liability law.

No aspect of this or any advertisement has been approved by the Supreme Court of New Jersey or a court or authority of any jurisdiction. Selection methodology for Law360 MVP can be found here.

Related News

July 28, 2026
Seeger Weiss Named Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards

Seeger Weiss has been named as Pharmaceutical Litigation Practice Group of the Year at the National Law Journal’s 2026 Elite Trial Lawyers Awards. This honor is reflects to the Seeger Weiss team’s efforts throughout the entire Pharmaceutical Litigation practice area, but specifically the firm’s work on the GLP-1 RA and Depo-Provera litigations. Partner Parvin Aminolroaya […]

Read More
July 28, 2026
Plaintiffs Reach Uncapped Global Settlement With J&J, Company to Pay Minimum of $5.8 Billion to Resolve Talc Litigation After More Than a Decade

The Plaintiffs’ Negotiation Committee in multi-district litigation 2738 (District of New Jersey), with the support and endorsement of the Plaintiffs’ Executive Committee and the Plaintiffs’ Steering Committee, announces today that it has reached a historic uncapped global settlement with J&J, Company to pay a minimum $5.8 billion settlement to resolve all current and pending talcum […]

Read More
June 29, 2026
Seeger Weiss Earns Tier 1 Ranking in the 2026 Legal 500 USA Guide

Seeger Weiss is proud to announce that the firm has been selected for a Tier 1 ranking in the 2026 Legal 500 USA Guide in the Product Liability, Mass Tort and Class Action: Plaintiff category. Founding Partner Christopher Seeger was selected for inclusion in the category’s Hall of Fame in recognition of his continued leadership […]

Read More